PROGESTERONE by Eli Lilly and Company is clinical pharmacology progesterone capsules are an oral dosage form of micronized progesterone which is chemically identical to progesterone of ovarian origin. First approved in 1974.
Drug data last refreshed 19h ago · AI intelligence enriched 1w ago
Progesterone is an oral micronized progesterone capsule chemically identical to naturally occurring ovarian progesterone, designed to increase bioavailability through micronization technology. It is indicated for use in hormone replacement therapy, typically in combination with conjugated estrogens for postmenopausal women with an intact uterus. The drug works by mimicking endogenous progesterone to provide therapeutic hormone replacement and endometrial protection.
Product approaching loss of exclusivity with limited linked job openings (2 positions), indicating a mature, stable franchise with focused clinical staffing needs.
CLINICAL PHARMACOLOGY Progesterone capsules are an oral dosage form of micronized progesterone which is chemically identical to progesterone of ovarian origin. The oral bioavailability of progesterone is increased through micronization. Pharmacokinetics A. Absorption After oral administration of…
Worked on PROGESTERONE at Eli Lilly and Company? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Individualized Prolonged Luteal Support After Fresh Embryo Transfer in Women With Low Progesterone
Comparing the Pharmacokinetics of a Progesterone Ring Versus a Progesterone Vaginal Insert
Exogenous Progesterone as Ovulation Trigger
Comparison of Two Vaginal Progesterone Forms in Frozen Embryo Transfer
PD-1 Inhibitor Combined With Progesterone Treatment in FST for Patients With MMRd Endometrial Cancer
Eli Lilly and Company is hiring 2 roles related to this product
Working on Progesterone offers limited growth potential given the mature product status and approaching loss of exclusivity. Roles are concentrated in clinical management and practitioner support rather than commercial expansion, making this suitable for candidates seeking stable, clinically-focused positions over high-growth career trajectories.
2 open roles linked to this drug